© Reuters. Align Earnings, Revenue Beat in Q3
Investing.com – Align (NASDAQ:) reported on Wednesday third quarter that beat analysts’ forecasts and revenue that topped expectations.
Align announced earnings per share of $2.87 on revenue of $1.02B. Analysts polled by Investing.com anticipated EPS of $2.59 on revenue of $976.89M.
Align shares are down 5% from the beginning of the year, still down 18.00% from its 52 week high of $737.45 set on September 23. They are under-performing the Nasdaq which is up 18.21% from the start of the year.
Align shares gained 8.32% in after-hours trade following the report.
Align follows other major Healthcare sector earnings this month
Align’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment